Introduction
============

For many years, studies on *Chromobacterium violaceum* have been focused on investigating small molecules of biotechnological interest derived from its secondary metabolism, while aspects related to the pathogenicity of *C. violaceum* have been neglected. In fact, there are many reviews describing the biotechnological and pharmacological importance of *C. violaceum* and its secondary metabolites, mainly the purple pigment violacein ([@B16]; [@B15], [@B14]), but none have focused on the mechanisms of *C. violaceum* virulence. However, this situation has changed in recent years, with numerous works advancing toward revealing multiple facets of the biology of *C. violaceum* and its interaction with mammalian hosts ([@B35], [@B34]; [@B29]; [@B42]). In this work, we summarize recent advances in the knowledge of the pathogenesis of *C. violaceum* infections and update the scenario regarding clinical cases and deaths caused by *C. violaceum*. Moreover, we evaluate the presence and genomic organization of the genes encoding type III secretion systems (T3SSs) in members of the *Chromobacterium* genus.

Overview of the *Chromobacterium* Genus
---------------------------------------

*Chromobacterium* is a genus of soil- and freshwater-associated Gram-negative bacteria within the *Neisseriaceae* family of Betaproteobacteria. Despite its saprophytic, free-living lifestyle, the species type of the genus, *C. violaceum*, has been associated with infections in humans and other animals ([@B16]; [@B59]). One particular characteristic of this genus is the production of violacein, a purple pigment for which the synthesis is regulated by quorum sensing ([@B32]). However, non-pigmented isolates have also been identified ([@B45]). Violacein is a pigment with high biotechnological interest due to its *in vitro* activity against bacteria, fungi, protozoa, viruses, and tumor cells ([@B15], [@B14]). Environmental isolates of *Chromobacterium* have the potential to be used in other biotechnological applications, including biocontrol of plant diseases caused by insect pests (*Chromobacterium* sp. strain C-61) ([@B24]), prevention of disease transmission by *Anopheles gambiae* and *Aedes aegypti* mosquitoes (*Chromobacterium* sp. Csp_P) ([@B43]), hydrogen cyanide-mediated gold recovery from electronic waste ([@B52]), and production of the anti-tumoral depsipeptide FR901228 (*C. violaceum*) ([@B16]; [@B53]).

Although *C. violaceum* has been recognized as the single species of the *Chromobacterium* genus for a long time, nine novel species have been proposed since 2007: *C. subtsugae* ([@B30]), *C. aquaticum* ([@B60]), *C. haemolyticum* ([@B19]), *C. piscinae* ([@B22]), *C. pseudoviolaceum* ([@B22]), *C. vaccinii* ([@B49]), *C. amazonense* ([@B33]), *C. alkanivorans* ([@B4]), and *C. rhizoryzae* ([@B62]). Additionally, the great genetic variability found in *Chromobacterium* isolates collected from distinct tropical regions ([@B21]; [@B26]) supports the trend to attempt to recognize novel species. Most of the *Chromobacterium* species were isolated from environmental samples (mainly from water, soil, and rhizosphere) and have not yet been associated with human infections (**Table [1](#T1){ref-type="table"}**). Exceptions include *C. violaceum*, isolated from both environmental and clinical samples and associated with several cases of fatal infections ([@B59]), and *C. haemolyticum*, isolated from a patient's sputum culture ([@B19]) and associated with a human case of bacteremia ([@B39]). With respect to violacein production, the non-purple species of this genus are *C. aquaticum*, *C. haemolyticum*, *C. alkanivorans*, and *C. rhizoryzae* (**Table [1](#T1){ref-type="table"}**).

###### 

Summary of the *Chromobacterium* species and selected strains with genome sequences available.

  Species/strain with published genome^a^                                     Isolation source                                              Biological interaction               Colony color   Reference of genome sequencing
  --------------------------------------------------------------------------- ------------------------------------------------------------- ------------------------------------ -------------- --------------------------------
  *C. violaceum*/strains ATCC 12472 and CV017 (derived from ATCC 31532)       Soil and water worldwide; human infections                    Human and animal pathogen            Violet         [@B54]; [@B58]
  *C. subtsugae*/strains PRAA4-1; MWU12-2387; MWU3525; MWU2576; and MWU2920   Forest soil and rhizosphere in United States                  Toxic to insect larvae               Violet         [@B56], [@B57]; [@B7]
  *C. aquaticum*/strain CC-SEYA-1                                             Spring water in Taiwan                                        Non-described                        Tan            [@B47]
  *C. haemolyticum*/strain T124                                               Sputum from a patient in United States; bacteremia in Japan   Human pathogen                       Gray           [@B36]
  *C. piscinae*/strain ND17                                                   Pond water in Malaysia                                        Non-described                        Violet         [@B9]
  *C. pseudoviolaceum*/strain LMG 3953T                                       Unclear                                                       Non-described                        Violet         [@B48]
  *C. vaccinii*/strains MWU205 and MWU328                                     Soil and rhizosphere in United States                         Toxic to insect larvae               Violet         [@B55]
  *C. amazonense*                                                             River water in Brazil                                         Non-described                        Violet         --
  *C. alkanivorans*                                                           Contaminated soil in India                                    Degradation of halogenated alkanes   Tan            --
  *C. rhizoryzae*                                                             Rhizosphere in China                                          Inhibition of fungal pathogens       Tan            --
  *Chromobacterium* sp./strain C-61                                           Rhizosphere in Korea                                          Inhibition of fungal pathogens                      [@B25]
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Updates Regarding Clinical Reports of *Chromobacterium violaceum* Infections
----------------------------------------------------------------------------

Although rare, human infections with *C. violaceum* are associated with high mortality rates; bacteria spreading rapidly to several organs, especially the liver, lungs, and spleen; and life-threatening sepsis ([@B46]; [@B16]). The main clinical manifestations are fever, abdominal pain, skin lesions, and formation of metastatic abscesses. The most common route of transmission involves the exposure of wounds and traumatic lesions to soil and water containing *C. violaceum* ([@B31]; [@B16]; [@B5]; [@B3]). Due to the rapid clinical course of the chromobacteriosis, one important predisposing risk factor in *C. violaceum* infections is inappropriate antimicrobial therapy. It has been reported that *C. violaceum* is resistant to several antibiotics, mainly to some beta-lactams, but it is sensitive to others, such as carbapenems and quinolones ([@B1]). Indeed, most of the treatments which were successful in controlling infections involved the use of the antibiotics ciprofloxacin and meropenem ([@B37]; [@B23]; [@B8]; [@B40]).

The last comprehensive compilation of human cases of *C. violaceum* infection analyzed 106 patients with *C. violaceum* infections between 1952 and 2009 ([@B59]). Here, our update on the published clinical reports of *C. violaceum* infections (searching the PubMed database from 2010 to 2017) reveals that infections due to *C. violaceum* are still rare and are associated with high mortality (Supplementary Table [S1](#SM1){ref-type="supplementary-material"}). Overall, there are less than 150 published clinical reports describing human *C. violaceum* infections. During the period of our analysis, 23 new cases of human infection were reported, with a mortality rate of 35% (eight fatal cases) (Supplementary Table [S1](#SM1){ref-type="supplementary-material"}). This is a smaller value than what was seen at the time of the last update (53%) ([@B59]). The reduction in the rate of fatal cases could be attributed to an improvement in antibiotic administration or better diagnostics. The tendency for the distribution of cases to be worldwide was maintained in our compilation, despite the most fatal cases having been described in developing countries (Supplementary Table [S1](#SM1){ref-type="supplementary-material"}). Moreover, recent reports of *C. violaceum* infection found that, in addition to systemic infections, this bacterium causes urinary tract infections and pneumonia in hospital environments, which raises concerns about its potential as a nosocomial pathogen ([@B18]; [@B50]; [@B41], [@B40]).

In addition to *C. violaceum*, another species of potential medical interest in the same genus is *C. haemolyticum* (**Table [1](#T1){ref-type="table"}**). Although only a few cases of human *C. haemolyticum* infection have been reported so far, and none of them were fatal, this bacterium has shown remarkable hemolytic activity against human and sheep erythrocytes ([@B19]; [@B39]). It has several uncharacterized potential virulence factors, as predicted from the draft genome sequence of one clinical isolate ([@B36]). Interestingly, *C. haemolyticum* isolates collected from a tropical freshwater lake exhibited strong beta-hemolytic activity and high resistance to beta-lactam antibiotics, as observed in clinical isolates ([@B27]).

Molecular Pathogenesis of *C. violaceum* Infections
---------------------------------------------------

The sequencing of the complete genome of *C. violaceum* strain ATCC 12472 shed light on the virulence mechanisms of this bacterium by revealing the presence of many predicted virulence factors ([@B54]). The most remarkable of these predicted virulence factors was the type III secretion system (T3SS), which is a needle-like multiprotein complex that injects various bacterial effectors into host cells ([@B17]). Surprisingly, genomic data have revealed that *C. violaceum* has two T3SSs whose genes were clustered in *Chromobacterium* pathogenicity islands 1 and 2 (Cpi-1 and Cpi-2) ([@B54]; [@B2]). These islands were located next to each other on the chromosome, but while the genes from Cpi-2 were all grouped together, some genes from Cpi-1, encoding the needle complex, were located distantly from Cpi-1, in a cluster called the Cpi-1a ([@B6]). *C. violaceum* Cpi-1/1a and Cpi-2 resemble the well-characterized *Salmonella* pathogenicity islands Spi-1 and Spi-2 ([@B6]).

In 2010, it was demonstrated that deletion of genes from Cpi-1/1a, but not from Cpi-2, causes a profound reduction in *C. violaceum* virulence in a mouse model of infection, positioning Cpi-1/1a as the major determinant for *C. violaceum* pathogenicity ([@B35]). In addition, the capacity of *C. violaceum* to cause fulminant hepatitis in mice through the induction of cytotoxicity and cell death in hepatocytes was shown to be dependent on the Cpi-1/1a-encoded T3SS ([@B35]). Despite of the absence of a clear requirement for Cpi-2 for systemic infection by *C. violaceum* ([@B35]), more studies are necessary to understand the role of this T3SS in the interaction of *C. violaceum* with host cells. Cpi-2 could be involved in the survival of *C. violaceum* within macrophages, as described for the *Salmonella* Spi-2 system ([@B20]).

Further investigations demonstrated that the repertoire of Cpi-1/1a-encoded T3SS effectors translocated into hepatocytes includes at least 16 effector proteins, but the role of the most of them have yet to be determined ([@B35], [@B34]). The authors discovered that one of these effectors, called CopE, plays a key role in *C. violaceum* invasion of non-phagocytic epithelial cells and is required for *C. violaceum* virulence in mice ([@B34]). This study demonstrated that CopE acts as a guanine exchange factor (GEF) that activates Rac1 and Cdc42 in HeLa cells, resulting in the induction of actin rearrangement. Consequently, this promotes *C. violaceum* invasion of non-phagocytic cells ([@B34]). Interestingly, it has been recently discovered that *C. violaceum* escapes from the phagosome to the cytosol in epithelial cells by a mechanism involving CipC, a translocon apparatus protein of the Cpi-1 T3SS ([@B13]).

The roles of transcriptional regulators in *C. violaceum* virulence have been investigated. For instance, a study based on expression and mutagenesis analyses of five putative regulators located within the Cpi-1 and Cpi-2 islands (CilA, CivF, ArmR, CsrB, and CsrC) revealed that CilA is the master transcriptional activator of most of the Cpi-1/1a genes ([@B34]). This is consistent with the previous finding that a *cilA*-mutant strain was fully attenuated for virulence in mice ([@B35]). The signals that turn on the expression of the CilA-regulated genes in *C. violaceum*, including the Cpi-1/1a genes, remain largely unknown. More recently, it has been reported that the MarR family transcriptional regulator OhrR is important for the virulence of *C. violaceum* in mice ([@B42]). In *C. violaceum*, OhrR is a sensor of organic hydroperoxides that regulates the expression of a few genes related to antioxidant defense, synthesis of cyclic di-GMP, and the production of virulence-related, secreted enzymes ([@B11]; [@B42]). Finally, the involvement of a quorum sensing system in the ability of *C. violaceum* to kill *Caenorhabditis elegans* has been determined ([@B51]), allowing this nematode to be used as an alternative model for identifying virulence genes of *C. violaceum*.

An elegant study demonstrated that the molecular detection of *C. violaceum* by human macrophages involves the recognition of the Cpi-1a T3SS needle protein CprI by the NAIP protein; human NAIP recognizes CprI and promotes Nod-like receptor CARD domain-containing protein 4 (NLRC4) inflammasome oligomerization, which is followed by caspase-1 activation and pyroptosis ([@B61]). Subsequent investigations using a murine model revealed that *C. violaceum* infection is promptly controlled in healthy mice by the NLRC4 inflammasome via two pathways that release bacteria from intracellular niches: pyroptosis and Natural Killer (NK) cell cytotoxicity ([@B29]). These mechanisms eject the intracellular bacteria from macrophages and hepatocytes and expose them to the action of neutrophils ([@B29]). In fact, neutrophil deficiencies in NADPH oxidase, as seen in patients with chronic granulomatous disease (CGD), drastically increase susceptibility to *C. violaceum* infections ([@B44]; [@B59]; [@B29]). In addition, it was verified that knockout mice in these immune system pathways are extremely susceptible to infection by *C. violaceum* and *Burkholderia thailandensis*, two CGD-associated pathogens ([@B29]). Therefore, a hypothesis was proposed, stating that inflammasomes evolved as a form of defense against infection due to environmental bacteria with virulence traits that did not evolve with vertebrate hosts ([@B28]).

Prevalence of T3SSs in the *Chromobacterium* Genus
--------------------------------------------------

Bacterial T3SSs have been demonstrated to be key determinants of virulence for many Gram-negative plant and animal pathogens via delivery of effector proteins into the cytosol of host eukaryotic cells ([@B12]). Gene clusters encoding T3SSs are also found in genomes of non-pathogenic bacteria, and the roles of these T3SSs are not restricted to pathogenesis, but seem to include other processes during interactions involving bacteria and their hosts in diverse ecological contexts ([@B38]). As mentioned above, earlier genome sequencing of the strain type *C. violaceum* ATCC 12472 revealed the presence of two T3SSs (Cpi-1/1a and Cpi-2), of which, Cpi-1/1a is absolutely required for virulence ([@B54]; [@B35]). Recently, several draft genome sequences of *Chromobacterium* species were published (**Table [1](#T1){ref-type="table"}**) and many other have become publicly available (39 *Chromobacterium* genomes, as searched on 15 June, 2017 in the NCBI GenBank database), allowing for a detailed inspection of the occurrence and organization of T3SSs in members of the *Chromobacterium* genus and among strains of the same species.

We performed such an analysis by searching for genes of the Cpi-1/1a- and Cpi-2-encoded T3SSs of *C. violaceum* ATCC 12472 in the draft genome sequences of 22 *Chromobacterium* species/strains (Supplementary Table [S2](#SM2){ref-type="supplementary-material"}), using tools available in the Integrated Microbial Genomes and Microbiome (IMG/M) system ([@B10]). Some interesting findings arose from this analysis (Supplementary Table [S2](#SM2){ref-type="supplementary-material"} and **Figure [1](#F1){ref-type="fig"}**): (i) the widespread occurrence of the Cpi-1/1a T3SS in the *Chromobacterium* genus, since its absence was observed only in *C. piscinae* (Supplementary Table [S2](#SM2){ref-type="supplementary-material"}); (ii) the existence of two genomic organizations for the Cpi-1/1a genes, which were found either as two separated gene clusters (Cpi-1 and Cpi-1a, as seen in **Figure [1A](#F1){ref-type="fig"}**, for instance in *C. violaceum* strains), or as a single cluster of contiguous genes (Cpi-1, as seen in **Figure [1B](#F1){ref-type="fig"}**, for instance in *C. subtsugae* strains); and (iii) the narrow distribution of Cpi-2 in the *Chromobacterium* genus, since the occurrence of most Cpi-2 genes was restricted to *C. piscinae* and *C. vaccinii* (Supplementary Table [S2](#SM2){ref-type="supplementary-material"}). These data support the hypothesis that the presence of Cpi-1 is ancient in the *C. violaceum* genome (and perhaps in the *Chromobacterium* genus) and that Cpi-2 was acquired more recently ([@B6]).

![Genomic organization of *Chromobacterium* pathogenicity island 1 (Cpi-1) in members of the *Chromobacterium* genus. The T3SS genes are either split into two gene clusters (Cpi-1/1a) **(A)**; or grouped together (Cpi-1) on the chromosome **(B)**. Comparison was performed using T3SS gene clusters from *C. violaceum* ATCC 12472 (Cpi-1a, CV2417-CV2423 and Cpi-1, CV2615-CV2642) as previously annotated ([@B6]). Genes are colored according to functional category (genes in gray are that absent in *C. violaceum* ATCC 12472). For *C. vaccinii*, the two genes surrounded in blue are present only in MWU205 strain.](fmicb-08-02213-g001){#F1}

Concluding Remarks and Perspectives
===================================

In recent years, we have begun to learn how *C. violaceum* causes severe infection in mammalian hosts, despite its evolution as an environmental free-living bacterium. Evolutionarily, the most relevant event that makes it an opportunistic pathogen is very likely to be the acquisition and/or maintenance of Cpi-1, a pathogenicity island containing the T3SS, which is essential for *C. violaceum* virulence. This T3SS is important for the pathogenesis of *C. violaceum* because it causes damage to hepatocytes and promotes the invasion of non-phagocytic cells. Also, it is the signal that triggers activation of the NLRC4 inflammasome, resulting in an effective clearance of the infection by the innate immune system. The widespread occurrence of intact Cpi-1 in many *Chromobacterium* species (most of them isolated from environmental sources and yet not associated with human infection) raises questions about the potential of these species to be pathogenic for humans. An alternative hypothesis is that the Cpi-1 T3SS contributes to the interaction of *Chromobacterium* with other organisms. In fact, several *Chromobacterium* species have been isolated from the roots of plants and are able to suppress plant disease by killing insect larvae or antagonize fungal pathogens. Future studies involving the T3SSs and other virulence factors of *C. violaceum* will contribute to a better understanding of the pathogenesis of this rare but deadly human pathogen.
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